Raamdeo Agrawal, the boss man of Motilal Oswal, recommended a stock on the basis that it has a huge “competitive advantage” and other stellar virtues. Unfortunately, the stock now faces the ignominy of being downgraded by Motilal Oswal itself owing to “competitive pressures ”
Brahmal Vasudevan’s Latinia has pocketed a mind-boggling gain of 400% from a small-cap stock in just 30 months. However, the stock deserves to bought even now because it has a lot more gains packed into it claims Motilal Oswal
Brahmal Vasudevan’s Creador Capital pocketed 450% gains from their last stock pick, Chola Finance. Their latest stock pick is of the same top-quality and pedigree and has the potential to give mega gains say eminent experts
Dharmesh Kant, now with Motilal Oswal, is diligently discharging his responsibility of identifying winning stocks and recommending them to us. He has now homed in on a top-quality stock which stands to benefit from the demand for specialty chemicals and pharmaceuticals
Basant Maheshwari’s stock picking mastery has enabled him to pocket mega gains from a “Rajnikant” style stock even as his PMS is growing in strength
Emkay has claimed that a mid-cap Pharma stock, which is already certified as a potential “100-bagger”, has made a “giant leap” and deserves to be accumulated
While Porinju Veliyath has confidently asserted that his favourite Pharma stock can give up to 100% gains in 2 years, Daljeet Kohli is cautious and has recommended a sell. Both stalwarts have given cogent reasons in support of their respective stands. Which one will be proved right?
Renuka Ramnath of Multiples Equity and Brahmal Vasudevan of Creador follow the salutary practice of investing only in top-quality mid-cap stocks. This has enabled the duo to earn high returns with virtually no risk to their capital
Daljeet Kohli’s recomm endation of a mid-cap banking stock has gone off well. He has increased his target price and promised more gains from it. Other eminent experts are also bullish about the stock
A small-cap specialty chemicals stock with powerhouse credentials and which was one of the favourites of Jwalamukhi/ Westbridge Capital has come back into the reckoning with several leading experts recommending a buy
Recent Comments